219 related articles for article (PubMed ID: 35869598)
1. Sex-specific effects of microglial activation on Alzheimer's disease proteinopathy in older adults.
Casaletto KB; Nichols E; Aslanyan V; Simone SM; Rabin JS; La Joie R; Brickman AM; Dams-O'Connor K; Palta P; Kumar RG; George KM; Satizabal CL; Schneider J; Pa J
Brain; 2022 Oct; 145(10):3536-3545. PubMed ID: 35869598
[TBL] [Abstract][Full Text] [Related]
2. Microglial Correlates of Late Life Physical Activity: Relationship with Synaptic and Cognitive Aging in Older Adults.
Casaletto KB; Lindbergh CA; VandeBunte A; Neuhaus J; Schneider JA; Buchman AS; Honer WG; Bennett DA
J Neurosci; 2022 Jan; 42(2):288-298. PubMed ID: 34810231
[TBL] [Abstract][Full Text] [Related]
3. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
Streit WJ; Braak H; Xue QS; Bechmann I
Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
[TBL] [Abstract][Full Text] [Related]
4. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease.
Dani M; Wood M; Mizoguchi R; Fan Z; Walker Z; Morgan R; Hinz R; Biju M; Kuruvilla T; Brooks DJ; Edison P
Brain; 2018 Sep; 141(9):2740-2754. PubMed ID: 30052812
[TBL] [Abstract][Full Text] [Related]
5. Associations between sex, body mass index and the individual microglial response in Alzheimer's disease.
Biechele G; Rauchmann BS; Janowitz D; Buerger K; Franzmeier N; Weidinger E; Guersel S; Schuster S; Finze A; Harris S; Lindner S; Albert NL; Wetzel C; Rupprecht R; Rominger A; Palleis C; Katzdobler S; Burow L; Kurz C; Zaganjori M; Trappmann LK; Goldhardt O; Grimmer T; Haeckert J; Keeser D; Stoecklein S; Morenas-Rodriguez E; Bartenstein P; Levin J; Höglinger GU; Simons M; Perneczky R; Brendel M
J Neuroinflammation; 2024 Jan; 21(1):30. PubMed ID: 38263017
[TBL] [Abstract][Full Text] [Related]
6. The relationship between the morphological subtypes of microglia and Alzheimer's disease neuropathology.
Paasila PJ; Davies DS; Kril JJ; Goldsbury C; Sutherland GT
Brain Pathol; 2019 Nov; 29(6):726-740. PubMed ID: 30803086
[TBL] [Abstract][Full Text] [Related]
7. Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge.
Cousins O; Schubert JJ; Chandra A; Veronese M; Valkimadi P; Creese B; Khan Z; Arathimos R; Hampshire A; Rosenzweig I; Ballard C; Corbett A; Aasland D; Velayudhan L; O'Neill M; Collier D; Awais R; Sander K; Årstad E; Howes O; Turkheimer F; Hodges A
J Neuroinflammation; 2023 Nov; 20(1):272. PubMed ID: 37990275
[TBL] [Abstract][Full Text] [Related]
8. Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline.
Rabin JS; Nichols E; La Joie R; Casaletto KB; Palta P; Dams-O'Connor K; Kumar RG; George KM; Satizabal CL; Schneider JA; Pa J; Brickman AM
Brain; 2022 Aug; 145(8):2823-2833. PubMed ID: 35759327
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's pathology targets distinct memory networks in the ageing brain.
Maass A; Berron D; Harrison TM; Adams JN; La Joie R; Baker S; Mellinger T; Bell RK; Swinnerton K; Inglis B; Rabinovici GD; Düzel E; Jagust WJ
Brain; 2019 Aug; 142(8):2492-2509. PubMed ID: 31199481
[TBL] [Abstract][Full Text] [Related]
10. Review: experimental manipulations of microglia in mouse models of Alzheimer's pathology: activation reduces amyloid but hastens tau pathology.
Lee DC; Rizer J; Hunt JB; Selenica ML; Gordon MN; Morgan D
Neuropathol Appl Neurobiol; 2013 Feb; 39(1):69-85. PubMed ID: 23171029
[TBL] [Abstract][Full Text] [Related]
11. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory components in human Alzheimer's disease and after active amyloid-β42 immunization.
Zotova E; Bharambe V; Cheaveau M; Morgan W; Holmes C; Harris S; Neal JW; Love S; Nicoll JA; Boche D
Brain; 2013 Sep; 136(Pt 9):2677-96. PubMed ID: 23943781
[TBL] [Abstract][Full Text] [Related]
13. An early and late peak in microglial activation in Alzheimer's disease trajectory.
Fan Z; Brooks DJ; Okello A; Edison P
Brain; 2017 Mar; 140(3):792-803. PubMed ID: 28122877
[TBL] [Abstract][Full Text] [Related]
14. TREM2 gene expression associations with Alzheimer's disease neuropathology are region-specific: implications for cortical versus subcortical microglia.
Winfree RL; Seto M; Dumitrescu L; Menon V; De Jager P; Wang Y; Schneider J; Bennett DA; Jefferson AL; Hohman TJ
Acta Neuropathol; 2023 Jun; 145(6):733-747. PubMed ID: 36966244
[TBL] [Abstract][Full Text] [Related]
15. Distinct amyloid-β and tau-associated microglia profiles in Alzheimer's disease.
Gerrits E; Brouwer N; Kooistra SM; Woodbury ME; Vermeiren Y; Lambourne M; Mulder J; Kummer M; Möller T; Biber K; Dunnen WFAD; De Deyn PP; Eggen BJL; Boddeke EWGM
Acta Neuropathol; 2021 May; 141(5):681-696. PubMed ID: 33609158
[TBL] [Abstract][Full Text] [Related]
16. Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease.
Shinohara M; Fujioka S; Murray ME; Wojtas A; Baker M; Rovelet-Lecrux A; Rademakers R; Das P; Parisi JE; Graff-Radford NR; Petersen RC; Dickson DW; Bu G
Brain; 2014 May; 137(Pt 5):1533-49. PubMed ID: 24625695
[TBL] [Abstract][Full Text] [Related]
17. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
18. Neuroinflammation is increased in the parietal cortex of atypical Alzheimer's disease.
Boon BDC; Hoozemans JJM; Lopuhaä B; Eigenhuis KN; Scheltens P; Kamphorst W; Rozemuller AJM; Bouwman FH
J Neuroinflammation; 2018 May; 15(1):170. PubMed ID: 29843759
[TBL] [Abstract][Full Text] [Related]
19. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
[TBL] [Abstract][Full Text] [Related]
20. sTREM2 is associated with attenuated tau aggregate accumulation in the presence of amyloid-β pathology.
Nabizadeh F
Brain Commun; 2023; 5(6):fcad286. PubMed ID: 37942087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
